The Fly | EVMN

Evommune, Inc.

· EVMN

Dashboard

Financials

Ratios

Valuation

Monday

Apogee deal gives positive readthrough to Evommune pipeline, says Clear Street

Jun 22, 5:53 PM

Canaccord sees potential Apogee buyout as 'huge win' for sector

Jun 22, 6:45 AM

Over a week ago

Evommune price target raised by $1 at Morgan Stanley

EVMN

May 11, 8:16 AM

Evommune reports Q1 EPS (64c), consensus (71c)

EVMN

May 7, 4:55 PM

Evommune initiated with bullish view at Stifel, here's why

EVMN

Apr 30, 4:19 PM

Six new option listings on April 23rd

Apr 23, 8:30 AM

Evommune files to sell 4.49M shares of common stock for holders

EVMN

Apr 17, 4:07 PM

Evommune assumed with an Outperform at Oppenheimer

EVMN

Apr 7, 8:45 AM

Block upgraded, Starbucks downgraded: Wall Street's top analyst calls

+12

Mar 18, 9:34 AM

Evommune price target lowered by $15 at H.C. Wainwright, here's why

EVMN

Mar 18, 6:06 AM

Evommune initiated with bullish view at Clear Street, here's why

EVMN

Mar 17, 4:24 PM

Evommune initiated with bullish view at RBC Capital, here's why

EVMN

Mar 10, 6:06 AM

Evommune reports Q4 EPS ($1.43), consensus (84c)

EVMN

Mar 5, 4:03 PM

Evommune price target raised by $18 at Morgan Stanley, here's why

EVMN

Feb 18, 1:16 PM

Evommune announces $125M private placement

EVMN

Feb 12, 8:34 PM

Evommune price target raised by $15 at Evercore ISI, here's why

EVMN

Feb 10, 1:28 PM

Evommune price target raised by $30 at H.C. Wainwright, here's why

EVMN

Feb 10, 12:53 PM

Midday Fly By: Coca-Cola reports Q4 beat, BP suspends buyback

+27

Feb 10, 12:12 PM

Evommune jumps 67% to $28.13 after atopic dermatitis data

EVMN

Feb 10, 8:27 AM

Evommune reports EVO301 trial met primary endpoint

EVMN

Feb 10, 7:37 AM

Evommune management to meet with Oppenheimer

EVMN

Jan 28, 3:50 PM

Evommune initiated with bullish view at Oppenheimer, here's why

EVMN

Jan 22, 8:12 AM

Evommune participates in a conference call with William Blair

EVMN

Jan 8, 4:55 AM

Charts

Monday

Apogee deal gives positive readthrough to Evommune pipeline, says Clear Street

Jun 22, 5:53 PM

Canaccord sees potential Apogee buyout as 'huge win' for sector

Jun 22, 6:45 AM

Over a week ago

Evommune price target raised by $1 at Morgan Stanley

EVMN

May 11, 8:16 AM

Evommune reports Q1 EPS (64c), consensus (71c)

EVMN

May 7, 4:55 PM

Evommune initiated with bullish view at Stifel, here's why

EVMN

Apr 30, 4:19 PM

Six new option listings on April 23rd

Apr 23, 8:30 AM

Evommune files to sell 4.49M shares of common stock for holders

EVMN

Apr 17, 4:07 PM

Evommune assumed with an Outperform at Oppenheimer

EVMN

Apr 7, 8:45 AM

Block upgraded, Starbucks downgraded: Wall Street's top analyst calls

+12

Mar 18, 9:34 AM

Evommune price target lowered by $15 at H.C. Wainwright, here's why

EVMN

Mar 18, 6:06 AM

Evommune initiated with bullish view at Clear Street, here's why

EVMN

Mar 17, 4:24 PM

Evommune initiated with bullish view at RBC Capital, here's why

EVMN

Mar 10, 6:06 AM

Evommune reports Q4 EPS ($1.43), consensus (84c)

EVMN

Mar 5, 4:03 PM

Evommune price target raised by $18 at Morgan Stanley, here's why

EVMN

Feb 18, 1:16 PM

Evommune announces $125M private placement

EVMN

Feb 12, 8:34 PM

Evommune price target raised by $15 at Evercore ISI, here's why

EVMN

Feb 10, 1:28 PM

Evommune price target raised by $30 at H.C. Wainwright, here's why

EVMN

Feb 10, 12:53 PM

Midday Fly By: Coca-Cola reports Q4 beat, BP suspends buyback

+27

Feb 10, 12:12 PM

Evommune jumps 67% to $28.13 after atopic dermatitis data

EVMN

Feb 10, 8:27 AM

Evommune reports EVO301 trial met primary endpoint

EVMN

Feb 10, 7:37 AM

Evommune management to meet with Oppenheimer

EVMN

Jan 28, 3:50 PM

Evommune initiated with bullish view at Oppenheimer, here's why

EVMN

Jan 22, 8:12 AM

Evommune participates in a conference call with William Blair

EVMN

Jan 8, 4:55 AM

Company News

Evommune, Inc.

· EVMN

Dashboard

Financials

Ratios

Valuation

Company News

Charts

Charts

Evommune, Inc.

· EVMN

Dashboard

Financials

Ratios

Valuation